Deltex Medical Group plc.Deltex Medical Group plc.Deltex Medical Group plc.

Deltex Medical Group plc.

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪3.20 M‬USD
‪−1.60 M‬USD
‪2.26 M‬USD
‪1.18 B‬
Beta (1Y)
0.97

About DELTEX MEDICAL GROUP ORD GBP0.0001

CEO
Andrew Jonathan Mears
Website
Headquarters
Chichester
Employees (FY)
37
Founded
2000
ISIN
GB0059337583
FIGI
BBG000BS9T02
Deltex Medical Group Plc engages in manufacturing and sale of advanced haemodynamic monitoring technologies. It operates through the following four segments: Probes, Monitors, Third Party Products and Other. Its products include ODM+, Dopplers Probes, HD Impedeance Cardiography, Cerebral Oximetry and Laryngoscopes. The company was founded on January 6, 2000 and is headquartered in Chichester, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DTXMF is 0.0013 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Deltex Medical Group plc. stocks are traded under the ticker DTXMF.
Deltex Medical Group plc. is going to release the next earnings report on Sep 23, 2024. Keep track of upcoming events with our Earnings Calendar.
DTXMF stock is 0% volatile and has beta coefficient of 0.97. Check out the list of the most volatile stocks — is Deltex Medical Group plc. there?
Deltex Medical Group plc. revenue for the last quarter amounts to ‪1.41 M‬ USD despite the estimated figure of ‪1.46 M‬ USD. In the next quarter revenue is expected to reach ‪1.40 M‬ USD.
Yes, you can track Deltex Medical Group plc. financials in yearly and quarterly reports right on TradingView.
DTXMF net income for the last quarter is ‪−915.29 K‬ USD, while the quarter before that showed ‪−682.88 K‬ USD of net income which accounts for −34.03% change. Track more Deltex Medical Group plc. financial stats to get the full picture.
Today Deltex Medical Group plc. has the market capitalization of ‪3.20 M‬, it has increased by 6.88% over the last week.
No, DTXMF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DTXMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Deltex Medical Group plc. stock right from TradingView charts — choose your broker and connect to your account.
DTXMF reached its all-time high on Jul 18, 2023 with the price of 0.9899 USD, and its all-time low was 0.0013 USD and was reached on Oct 23, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has 37.00 employees. See our rating of the largest employees — is Deltex Medical Group plc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Deltex Medical Group plc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Deltex Medical Group plc. stock shows the strong sell signal. See more of Deltex Medical Group plc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Deltex Medical Group plc. EBITDA is ‪−1.04 M‬ USD, and current EBITDA margin is −44.82%. See more stats in Deltex Medical Group plc. financial statements.